Hope Funds For Cancer Research
Hope Funds For Cancer Research maintains positive net assets with zero reported officer compensation amidst fluctuating revenues.
EIN: 205799367 · Newport, RI · NTEE: H123 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $676K |
| Total Expenses | $517K |
| Program Spending | 85% |
| Net Assets | $631K |
| Transparency Score | 90/100 |
Is Hope Funds For Cancer Research Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Hope Funds For Cancer Research directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Hope Funds For Cancer Research
Hope Funds For Cancer Research (EIN: 205799367) is a nonprofit organization based in Newport, RI, classified under NTEE code H123. The organization reported total revenue of $676K and total assets of $1.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Hope Funds For Cancer Research's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Hope Funds For Cancer Research is a small nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 2.2%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $752K |
| Total Expenses | $517K |
| Surplus / Deficit | +$235K |
| Total Assets | $1.0M |
| Total Liabilities | $400K |
| Net Assets | $631K |
| Operating Margin | 31.3% |
| Debt-to-Asset Ratio | 38.8% |
| Months of Reserves | 23.9 months |
Financial Health Grade: A
In 2023, Hope Funds For Cancer Research reported a surplus of $235K with revenue exceeding expenses, holds 23.9 months of operating reserves (strong position), has a debt-to-asset ratio of 38.8% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Hope Funds For Cancer Research's revenue has grown at a compound annual growth rate (CAGR) of 2.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +137.3% | +92.1% | +15.8% |
| 2022 | -57.4% | -68.0% | -8.4% |
| 2021 | +69.2% | +52.8% | +9.2% |
| 2020 | -28.3% | -30.9% | -64.8% |
| 2019 | -15.3% | +43.6% | +1.0% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Hope Funds For Cancer Research with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Hope Funds For Cancer Research allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $235K, with revenue exceeding expenses.
- Debt-to-asset ratio: 38.8%.
Executive Compensation Analysis
Hope Funds For Cancer Research consistently reports 0% officer compensation across all available filings, indicating that executive leadership is not compensated, which is a strong positive for directing funds to the mission.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Hope Funds For Cancer Research's IRS 990 filings:
- Significant decrease in total assets from $2.5M in 2017 to $1.0M in 2023
- Periods where expenses exceeded revenue (e.g., 2021, 2020, 2019, 2015)
Strengths
The following positive indicators were identified for Hope Funds For Cancer Research:
- Consistent 0% officer compensation across all filings
- Generally maintains positive net assets
- Strong program focus implied by lack of executive compensation
- Consistent IRS 990 filing history (13 filings)
Frequently Asked Questions about Hope Funds For Cancer Research
Is Hope Funds For Cancer Research a legitimate charity?
Based on AI analysis of IRS 990 filings, Hope Funds For Cancer Research (EIN: 205799367) some concerns. Mission Score: 90/100. 2 red flags identified, 4 strengths noted.
How does Hope Funds For Cancer Research spend its money?
Hope Funds For Cancer Research directs 85% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Hope Funds For Cancer Research tax-deductible?
Hope Funds For Cancer Research is registered as a tax-exempt nonprofit (EIN: 205799367). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Hope Funds For Cancer Research's spending goes to programs?
Hope Funds For Cancer Research directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Hope Funds For Cancer Research compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), Hope Funds For Cancer Research is above average for NTEE category H123 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Hope Funds For Cancer Research located?
Hope Funds For Cancer Research is headquartered in Newport, Rhode Island and files with the IRS under EIN 205799367. It is classified under NTEE code H123.
How many years of IRS 990 filings does Hope Funds For Cancer Research have?
Hope Funds For Cancer Research has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $676K in total revenue.
Is Hope Funds For Cancer Research a good charity?
Based on the provided data, Hope Funds For Cancer Research appears to be a good charity. It consistently reports 0% officer compensation, indicating a strong commitment to directing funds towards its mission. The organization generally maintains positive net assets, and its expenses are often below revenue, suggesting sound financial management.
How has the organization's asset base changed over time?
The organization's assets have seen a significant decrease from a peak of $2,549,665 in 2017 to $1,031,079 in 2023. While still positive, this trend warrants further investigation into the reasons for the decline.
What is the trend in revenue and expenses?
Revenue has been highly variable, ranging from $316,970 in 2022 to $1,311,399 in 2016. Expenses have also fluctuated but have often been managed below revenue, as seen in 2023 ($752,179 revenue vs. $516,774 expenses), though there were periods where expenses exceeded revenue (e.g., 2021, 2020, 2019, 2015).
Filing History
IRS 990 filing history for Hope Funds For Cancer Research showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Hope Funds For Cancer Research's revenue has grown by 29.9%, moving from $579K to $752K. Total assets increased by 20.8% over the same period, from $854K to $1.0M. Total functional expenses rose by 47.4%, from $351K to $517K. In its most recent filing year (2023), Hope Funds For Cancer Research reported a surplus of $235K, with revenue exceeding expenses. The organization holds $400K in liabilities against $1.0M in assets (debt-to-asset ratio: 38.8%), resulting in net assets of $631K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $752K | $517K | $1.0M | $400K | — | View 990 |
| 2022 | $317K | $269K | $891K | $495K | — | View 990 |
| 2021 | $744K | $841K | $972K | $656K | — | View 990 |
| 2020 | $440K | $550K | $890K | $494K | — | View 990 |
| 2019 | $613K | $796K | $2.5M | $569K | — | View 990 |
| 2018 | $724K | $554K | $2.5M | $589K | — | View 990 |
| 2017 | $772K | $535K | $2.5M | $642K | — | — |
| 2016 | $1.3M | $683K | $2.5M | $794K | — | View 990 |
| 2015 | $823K | $937K | $2.2M | $1.2M | — | View 990 |
| 2014 | $1.2M | $753K | $2.0M | $853K | — | View 990 |
| 2013 | $688K | $539K | $1.3M | $565K | — | View 990 |
| 2012 | $653K | $660K | $1.1M | $519K | — | View 990 |
| 2011 | $579K | $351K | $854K | $278K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $752K, expenses of $517K, and assets of $1.0M (revenue +137.3% year-over-year).
- 2022: Revenue of $317K, expenses of $269K, and assets of $891K (revenue -57.4% year-over-year).
- 2021: Revenue of $744K, expenses of $841K, and assets of $972K (revenue +69.2% year-over-year).
- 2020: Revenue of $440K, expenses of $550K, and assets of $890K (revenue -28.3% year-over-year).
- 2019: Revenue of $613K, expenses of $796K, and assets of $2.5M (revenue -15.3% year-over-year).
- 2018: Revenue of $724K, expenses of $554K, and assets of $2.5M (revenue -6.2% year-over-year).
- 2017: Revenue of $772K, expenses of $535K, and assets of $2.5M (revenue -41.1% year-over-year).
- 2016: Revenue of $1.3M, expenses of $683K, and assets of $2.5M (revenue +59.4% year-over-year).
- 2015: Revenue of $823K, expenses of $937K, and assets of $2.2M (revenue -31.8% year-over-year).
- 2014: Revenue of $1.2M, expenses of $753K, and assets of $2.0M (revenue +75.3% year-over-year).
- 2013: Revenue of $688K, expenses of $539K, and assets of $1.3M (revenue +5.4% year-over-year).
- 2012: Revenue of $653K, expenses of $660K, and assets of $1.1M (revenue +12.7% year-over-year).
- 2011: Revenue of $579K, expenses of $351K, and assets of $854K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Hope Funds For Cancer Research:
Data Sources and Methodology
This transparency report for Hope Funds For Cancer Research is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.